Epigenetic dysregulation in mycosis fungoides and sézary syndrome
Frontiers in Cell and Developmental Biology · 11.05.2026 · 14
DOI: 10.3389/fcell.2026.1813995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 11.05.2026. Verfasst von Vinícius de Camargo Callefi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Real-World Evidence Observatory and Lab for Precision Public Health, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Cutaneous T-cell lymphomas (CTCL), including mycosis fungoides (MF) and Sézary syndrome (SS), remain challenging to diagnose at early stages and to manage durably. Although staging and classification have improved, early MF can mimic benign inflammatory dermatoses, and advanced disease frequently develops resistance to standard therapies, including histone deacetylase (HDAC) inhibitors. Here, we summarize how aberrant DNA methylation and histone modifications contribute to CTCL pathogenesis, promote a permissive tumor microenvironment, and enable immune escape, as well as emerging epigenetic biomarkers, such as microRNA signatures and promoter hypermethylation, that may improve diagnostic accuracy and patient stratification. Finally, we discuss resistance mechanisms linked to epigenetic plasticity and intratumoral heterogeneity and highlight future strategies combining rational drug regimens with longitudinal single-cell profiling to improve the durability of response.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Real-World Evidence Observatory and Lab for Precision Public Health, Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy and…
- Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hemotherapy and Cell Therapy - Faculty of Medicine, University of São Paulo (FM-USP)…
- Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária - ANVISA), Brasília, Brazil.
- Department of Pharmaceutical Assistance and Strategic Inputs (DAF), Ministry of Health, Esplanada dos Ministérios, Brasília, Brazil.
- Cancer Institute of the State of São Paulo (ICESP) Octávio Frias de Oliveira, São Paulo, Brazil.
- Laboratory of Renal Physiology and Cardiometabolism, Department of Cardiopneumology, University of São Paulo (FMUSP), São Paulo, Brazil.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Callefi, V. C., Alves, I., De Aquino, N. C., Cattena, S., Santos, E., Vasconcelos, K., Culler, H. F., Alberto de Pádua Covas Lage, L., Rocha, V., Girardi, A. C. C., Sanches, J. A., Murga-Zamalloa, C. A., Pereira, J., & Reichert, C. O. (2026). Epigenetic dysregulation in mycosis fungoides and sézary syndrome. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1813995
Vancouver
Callefi VC, Alves I, De Aquino NC, Cattena S, Santos E, Vasconcelos K, et al. Epigenetic dysregulation in mycosis fungoides and sézary syndrome. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1813995
BibTeX
@article{Callefi2026,
author = {Callefi, Vinícius de Camargo and Alves, Isadora and De Aquino, Nélio Cézar and Cattena, Sofia and Santos, Emanuelle and Vasconcelos, Ketelyn and Culler, Hebert Fabricio and Alberto de Pádua Covas Lage, Luís and Rocha, Vanderson and Girardi, Adriana Castello Costa and Sanches, José Antonio and Murga-Zamalloa, Carlos Alejandro and Pereira, Juliana and Reichert, Cadiele Oliana},
title = {Epigenetic dysregulation in mycosis fungoides and sézary syndrome},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1813995}
}
EUVIMED